Gouy Sebastien, Saidani Marine, Maulard Amandine, Faron Matthieu, Bach-Hamba Slim, Bentivegna Enrica, Leary Alexandra, Pautier Patricia, Devouassoux-Shisheboran Mojgan, Genestie Catherine, Morice Philippe
Department of Gynecologic Surgery, Gustave Roussy, Villejuif, France.
Department of Gastro-intestinal Surgery, Gustave Roussy, Villejuif, France.
Gynecol Oncol Rep. 2017 Sep 1;22:21-25. doi: 10.1016/j.gore.2017.08.006. eCollection 2017 Nov.
The aim of this study is to determine the value of surgical staging for the two histologic types (expansile or infiltrative) of apparent stage I mucinous ovarian carcinoma. We retrospectively analyzed patients treated from 1976 and 2016 for apparent macroscopic stage I ovarian mucinous carcinoma. Extra-ovarian disease and tumors that metastasized to the ovaries were excluded. Two expert pathologists performed pathologic reviews of tumor data, according to 2014 WHO classification criteria. Tumors were typed as expansile or infiltrative and clinical and histologic characteristics were studied. The value of staging procedures (peritoneal and nodal) was based on the rate of microscopic involvement in macroscopically normal specimens. Of 114 cases reviewed, 46 were excluded (26 with macroscopic stage > I; 20 inaccessible for pathologic review). Of 68 patients included, 29 had expansile and 39 had infiltrative types. 27 patients received one-step surgery and 41 received restaging surgery. 52 patients received "complete" peritoneal surgical staging (including cytology, peritoneal biopsies, and an omentectomy or large omental biopsies). 24 underwent appendectomies and 31 underwent lymphadenectomies (8 expansile and 23 infiltrative). Before histologic analyses of staging specimens, 35 had "initial" stage IA and 33 had IC disease. After histologic analyses of lymph nodes, 4 cases (17%, all infiltrative) had nodal involvement, and 2 showed microscopic peritoneal disease (1 omentum and 1 right diaphragm peritoneum). Three patients were upstaged based on isolated positive peritoneal cytology. To conclude, peritoneal staging procedures are required for both types of mucinous ovarian carcinoma. Lymphadenectomy could be omitted in expansile, but required in infiltrative type.
本研究的目的是确定手术分期对表观I期黏液性卵巢癌两种组织学类型(膨胀性或浸润性)的价值。我们回顾性分析了1976年至2016年期间接受治疗的表观宏观I期卵巢黏液性癌患者。排除卵巢外疾病和转移至卵巢的肿瘤。两名专家病理学家根据2014年世界卫生组织分类标准对肿瘤数据进行了病理复查。将肿瘤分为膨胀性或浸润性,并研究其临床和组织学特征。分期程序(腹膜和淋巴结)的价值基于宏观正常标本中的微观受累率。在复查的114例病例中,46例被排除(26例宏观分期> I;20例无法进行病理复查)。在纳入的68例患者中,29例为膨胀性类型,39例为浸润性类型。27例患者接受了一期手术,41例接受了再次分期手术。52例患者接受了“完整”的腹膜手术分期(包括细胞学检查、腹膜活检和网膜切除术或大网膜活检)。24例接受了阑尾切除术,31例接受了淋巴结切除术(8例膨胀性和23例浸润性)。在对分期标本进行组织学分析之前,35例为“初始”IA期,33例为IC期。对淋巴结进行组织学分析后,4例(17%,均为浸润性)有淋巴结受累,2例显示微观腹膜疾病(1例大网膜和1例右膈肌腹膜)。3例患者因孤立的阳性腹膜细胞学检查而分期上调。总之,两种类型的黏液性卵巢癌都需要进行腹膜分期程序。膨胀性类型可省略淋巴结切除术,但浸润性类型需要进行。